Does diltiazem interact with statins?

Yes, significantly. Diltiazem inhibits CYP3A4, the enzyme that metabolizes many statins. This raises statin blood levels, increasing the risk of muscle damage (myopathy or rhabdomyolysis). Simvastatin over 10 mg and lovastatin over 20 mg should generally not be combined with diltiazem. Pravastatin, rosuvastatin, and low-dose fluvastatin are better alternatives. Discuss with your prescriber if you take a statin.

Why does diltiazem cause leg swelling?

Diltiazem relaxes smooth muscle in blood vessel walls, allowing blood vessels to dilate. This can cause fluid to shift into surrounding tissue, particularly in the lower legs, causing edema. Leg swelling is more common with dihydropyridine calcium channel blockers (like amlodipine) but can occur with diltiazem. Elevating legs, low-sodium diet, and compression stockings may help.

How is diltiazem different from amlodipine?

Both are calcium channel blockers, but they work on different tissues. Diltiazem (non-dihydropyridine) slows heart rate and is useful for rate control in AFib. Amlodipine (dihydropyridine) does not significantly affect heart rate. For hypertension alone, either can be used; for combined hypertension and AFib rate control, diltiazem is often preferred.

Can I take diltiazem with a beta-blocker?

The combination of diltiazem and a beta-blocker must be used with extreme caution. Both drugs slow the heart and suppress AV conduction — together they can cause dangerous bradycardia or complete heart block. This combination is sometimes used intentionally in highly monitored settings, but it requires careful prescriber oversight.

What to Expect When Starting Diltiazem

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Diltiazem is a non-dihydropyridine calcium channel blocker used to treat hypertension, angina, and atrial fibrillation or flutter. It lowers blood pressure and heart rate by reducing calcium influx into heart muscle and blood vessel smooth muscle cells. Unlike dihydropyridines (amlodipine, nifedipine), diltiazem slows the heart rate as well as lowering blood pressure.

Week-by-week timeline

Day 1-3

Starting Diltiazem

Diltiazem reduces heart rate and blood pressure within hours of the first dose. Common early side effects include dizziness, headache, flushing, and swelling of the legs (edema). Extended-release formulations provide more stable blood levels and are taken once or twice daily. Check your pulse and blood pressure if you have a home monitor.

Week 1

Adjustment Period

Headache and flushing often improve after the first week. Leg swelling, if present, may persist. Heart rate should be 60-90 bpm at rest; diltiazem should not lower resting rate below 50 bpm. Contact your prescriber if rate is below 50 or you feel dizzy or faint.

Week 2-4

Blood Pressure Stabilization

Full antihypertensive effects are typically established within 2 weeks. For rate control in AFib, heart rate targets should be achieved. Report persistent edema, significant bradycardia, or inadequate blood pressure control to your prescriber for possible dose adjustment.

Month 1

Assessment and Monitoring

Blood pressure, heart rate, and any side effects are assessed. Diltiazem can affect liver function in rare cases — liver enzymes may be checked. Drug interactions are important to review, particularly with simvastatin and other statins.

Month 2-3

Long-Term Stability

Most patients achieve stable, well-tolerated blood pressure and heart rate control. Persistent leg swelling can sometimes be managed with dose adjustment or by combining with a diuretic. Do not stop diltiazem abruptly, particularly if used for angina or AFib rate control.

When to call your doctor

Contact your healthcare provider if you experience:

Heart rate below 50 beats per minute at rest
Severe dizziness or fainting (may indicate excessive heart rate or blood pressure lowering)
Significant worsening of leg swelling
Chest pain or worsening angina
Yellowing of skin or eyes (rare liver toxicity)
Irregular heartbeat or worsening AFib symptoms
Severe headache
Signs of heart failure: worsening shortness of breath, rapid weight gain, difficulty lying flat

Tips for getting started

Do not take diltiazem with grapefruit juice — grapefruit significantly increases diltiazem blood levels by inhibiting metabolism. Check your pulse before each dose if on a higher dose — hold the dose and call your prescriber if below 50 bpm. Do not stop diltiazem abruptly, especially for angina. Extended-release formulations must be swallowed whole — do not crush or chew. Inform your prescriber of all medications, particularly statins, as diltiazem raises statin levels significantly (simvastatin and lovastatin especially).

Frequently asked questions

More about Diltiazem

Diltiazem drug guideSide effects, dosage, interactions, and more Amlodipine vs DiltiazemCompare these medications Diltiazem vs VerapamilCompare these medications Diltiazem & SimvastatinInteraction details

References

[Regulatory] FDA Label: Cardizem (diltiazem hydrochloride) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019029s041lbl.pdf Accessed 2026-03-01.
[Regulatory] NIH MedlinePlus: Diltiazem https://medlineplus.gov/druginfo/meds/a684027.html Accessed 2026-03-01.
[Regulatory] ACC/AHA AFib Guidelines: Rate Control https://www.jacc.org/doi/10.1016/j.jacc.2019.01.011 Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: March 1, 2026